Back

Optimizing and Validating Systemic DNA Damage Response Profiling to Predict Neoadjuvant Chemoradiation Response in Rectal Cancer

2024-11-23 oncology Title + abstract only
View on medRxiv
Show abstract

PurposeThis study aimed to stratify patients with locally advanced rectal cancer (LARC) based on their response to neoadjuvant chemoradiation therapy (nCRT) using DNA damage response (DDR)-related proteins measured in peripheral blood monocytes (PBMCs). We optimized and validated an innovative assay to quantify these proteins, providing a predictive framework for nCRT response. Experimental DesignWe used PBMCs collected from LARC patients either before or after standard course of [~]5.5 weeks o...

Predicted journal destinations